Common Contracts
6 similar Securities Exchange Agreement contracts by Agenus Inc, Antigenics Inc /De/
ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • March 16th, 2011 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is made as of December 28, 2010 by and between ANTIGENICS INC., a Delaware corporation (the “Company”), and INGALLS & SNYDER VALUE PARTNERS L.P. (the “Bond Holder”),
ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • March 16th, 2011 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is made as of November 2010 (the “Effective Date”) by and between ANTIGENICS INC., a Delaware corporation (the “Company”), and BRUCE FUND INC. (the “Bond Holder”),
ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • March 16th, 2011 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is made as of November 18, 2010 (the “Effective Date”) by and between ANTIGENICS INC., a Delaware corporation (the “Company”), and PROFESSIONAL LIFE & CASUALTY (the “Bond Holder”).
ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • March 16th, 2011 • Agenus Inc • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is made as of April 22, 2010 (the “Effective Date”) by and between ANTIGENICS INC., a Delaware corporation (the “Company”), and INVUS PUBLIC EQUITIES LP (the “Bond Holder”).
ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • August 10th, 2009 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is made as of June 4, 2009 (the “Effective Date”) by and between ANTIGENICS INC., a Delaware corporation (the “Company”), and The Wolverine Convertible Arbitrage Fund Trading Limited (the “Bond Holder”).
ANTIGENICS INC. SECURITIES EXCHANGE AGREEMENTSecurities Exchange Agreement • August 10th, 2009 • Antigenics Inc /De/ • Biological products, (no disgnostic substances) • New York
This Securities Exchange Agreement (this “Agreement”) is made as of June 3, 2009 (the “Effective Date”) by and between ANTIGENICS INC., a Delaware corporation (the “Company”), and TANG CAPITAL PARTNERS, LP (the “Bond Holder”).
